Entera Bio Ltd - Company Profile
Powered by 
All the sales intelligence you need on Entera Bio Ltd in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Entera Bio Ltd fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Entera Bio Ltd.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Entera Bio Ltd (Entera Bio) is a biopharmaceutical company that specializes in the oral delivery of molecules and biologics. The company develops novel drug delivery platforms for oral delivery of large molecule protein active pharmaceutical ingredients. Its pipeline products include EB613 for the treatment of osteoporosis and EB612 for the treatment of hyperparathyroidism. The company's other pipeline products include GLP-2 for short bowel syndrome and OXM for obesity and metabolic. Entera Bio utilizes N-Tab oral delivery technology platform, which is designed to simultaneously stabilize the peptide in the gastrointestinal tract and promote its absorption into the bloodstream. Entera Bio is headquartered in Jerusalem, Israel.
Headquarters
Israel
Address
Fifth Floor, Hadassah / Jerusalem Bio Park, 9112002
Website
enterabio.com
No of Employees
20
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
ENTX (NASD)
Revenue (2024)
$42,000
-76.8%
(2024 vs 2023)
EPS
XYZ
Net Income (2024)
XYZ
-19.9%
(2024 vs 2023)
Market Cap*
$105.0M
Net Profit Margin (2024)
XYZ
-416.7%
(2024 vs 2023)
* As of and is in US$
Entera Bio Ltd premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| EB612: Hypoparathyroidism | N-Tab |
| EB613: Osteoporosis and Stress Fractures | |
| GLP-2: Short Bowel Syndrom | |
| XYZ | |
| XYZ | |
| XYZ |
Competitor Comparison
| Key Parameters | Entera Bio Ltd | Compugen Ltd | BioLineRx Ltd | Chemomab Therapeutics Ltd |
|---|---|---|---|---|
| Headquarters | Israel | Israel | Israel | Israel |
| City | Jerusalem | Holon | Modi'in-Maccabim-Re'ut | Tel Aviv |
| State/Province | Jerusalem | Tel Aviv | - | Tel Aviv |
| No. of Employees | 20 | 75 | 24 | 12 |
| Entity Type | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Geno J. Germano | Chairman | Executive Board | 2026 | - |
| Miranda Toledano | Chief Executive Officer; Director | Executive Board | 2022 | 48 |
| Dana Yaacov Garbeli | Chief Financial Officer | Senior Management | 2022 | 41 |
| Hillel Galitzer | Chief Operating Officer | Senior Management | 2014 | 46 |
| Gregory Burshtein, PhD | Chief of Research and Development Officer | Senior Management | 2024 | 49 |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer